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A B S T R A C T
Peptide tags are extensively used for affinity purification of proteins. In an optimal case, these tags can be
completely removed from the purified protein by a specific protease mediated hydrolysis. However, the inter-
actions of these tags with the target protein may also be utilized for the modulation of the protein function. Here
we show that the C-terminal hexahistidine (6 × His) tag can influence the catalytic activity of the nuclease
domain of the Colicin E7 metallonuclease (NColE7) used by E. coli to kill competing bacteria under stress
conditions. This enzyme non-specifically cleaves the DNA that results in cytotoxicity. We have successfully
cloned the genes of NColE7 protein and its R447G mutant into a modified pET-21a DNA vector fusing the affinity
tag to the protein upon expression, which would be otherwise not possible in the absence of the gene of the Im7
inhibitory protein. This reflects the inhibitory effect of the 6 × His fusion tag on the nuclease activity, which
proved to be a complex process via both coordinative and non-specific steric interactions. The modulatory effect
of Zn2+ ion was observed in the catalytic activity experiments. The DNA cleavage ability of the 6 × His tagged
enzyme was first enhanced by an increase of metal ion concentration, while high excess of Zn2+ ions caused a
lower rate of the DNA cleavage. Modelling of the coordinative effect of the fusion tag by external chelators
suggested ternary complex formation instead of removal of the metal ion from the active center.
1. Introduction
Recently we reported about a new strategy of protein purification by
a C-terminal metal ion affinity fusion tag, using a new gene carrier
plasmid DNA. The self-eliminating BsmBI restriction enzyme sites al-
lowed for the insertion of the gene of the target protein between the atg
“start” codon and the nucleotide sequence encoding for the (Ser/Thr)-
X-His-X ((S/T)XHX) segment instead of the stop codon [1]. The latter
sequence can be hydrolyzed by Ni(II) ions at the N-terminus of the Ser/
Thr amino acid [2–7], and in this way, any kind of C-terminal affinity
tags can be easily removed from the expressed protein without leaving
any additional amino acids at the termini of the native protein se-
quence. Such peptide bond cleavage initiated by Ni(II) ions has already
found application in the affinity tag removal from fusion proteins
[8–10].
Oligohistidine fusion sequences are applied in metal ion affinity
chromatography due to their metal complexing ability through the
multiple imidazoles offered by the amino acid side chains. Although it
was shown that the affinity tags do not significantly affect the crystal
structures [11], they may influence the folding and thermal stability of
the protein, and/or its function through non-specific steric interactions.
Such effects have been observed in various proteins, exemplified by
refs. 12–23. His tag incorporation in myoglobin reduced the dynamics
of the protein motion, as demonstrated by the fluctuations of the CO
vibrational frequency [12]. The N-terminal His tag of the trimeric cy-
tokine tumor necrosis factor alpha (TNFα) led to a decrease of its cy-
totoxicity on the L-929 cell line by an order of magnitude, while the
removal of the tag re-established its normal biological activity [13]. The
incorporation of the C-terminal hexahistidine tag into tropinone re-
ductase showed steric and electrostatic interference with the active site
resulting in impaired KM value for nitrogen-containing substrates [14].
The His tag may also inhibit the binding of a peptide substrate by
competition [24].
Even more importantly, the oligohistidine sequences may co-
ordinate to metal ions [25–29]. This property may be utilized by la-
belling proteins with metal complexes [30,31] or nanoparticles [32,33],
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by immobilization on membranes [34] or metal ion derivatized surfaces
[35], as well as by introducing new functions [36,37]. The metal ions
bound within the metalloproteins may also be targeted by the oligo-
histidine coordination. Since metal ions play a role in the folding, sta-
bilization of the structure, catalytic activity and/or regulation of the
function of various metalloproteins, all these properties may be influ-
enced by the presence of the affinity tag. Such interactions are much
less discussed in the literature. As an example, the decrease in the re-
lease of iron from recombinant human serum transferrin was observed
in the presence of C-terminal His tag most likely due to the stabilization
of the metal ion by the complexation with the tag [38].
These findings highlight the possibility of tailoring the properties of
a selected metalloprotein by applying an oligohistidine fusion se-
quence. In the present paper we show, how the C-terminal hex-
ahistidine fusion tag can modulate the nuclease activity of the C-
terminal nuclease domain of the Colicin E7 metalloprotein (NColE7) via
both non-specific and coordinative interactions. To investigate this
phenomenon we have synthesized the genes of the NColE7-6 × His
protein (Scheme 1) and its selected mutants to express the proteins
within E. coli cells. Whenever it was possible, we also purified the
protein, for further characterization of its solution structure, metal ion-
binding and catalytic activity.
2. Experimental
2.1. Strains and media
Mach1 and DH5α competent E. coli cells were used for cloning the
recombinant DNA and BL21(DE3) competent E. coli cells for protein
expression. Bacteria were grown in lysogeny broth (LB) medium [39]
containing ampicillin in 0.1 mg/mL final concentration (amp+) at
37 °C. We checked the effect of NColE7 and its mutants on bacterial
colony formation on ampicillin containing LB(amp+) agar plates.
2.2. Plasmid construction
The new pET-21a*-SRHS plasmid DNA was modified from the pET-
21a commercial DNA vector. The new cloning site includes two BsmBI
restriction sites, the codes of SRHS (allowing to cleave the fusion tag in
the expressed protein by Ni(II), which can induce peptide-bond hy-
drolysis at the SRH sensitive sequence), a linker and a 6 × His tag
sequence. The genes of NColE7 (the original pQE70-NColE7/Im7
plasmid [40] was kindly provided by prof. Kin-Fu Chak from Institute of
Biochemistry, National Yang-Ming University, Taipei, Taiwan, Republic
of China) and its less active R447G mutant protein (further denoted as
KGNK) were cloned separately to yield the new protein expression DNA
constructs: pET-21a*-NColE7-SRHS and pET-21a*-KGNK-SRHS, ex-
pressing NColE7-6 × His (Scheme 1) and KGNK-6 × His proteins, re-
spectively. The codon of the histidine amino acid of the SRHS motif was
further mutated via a modified QuikChange™ protocol within both the
pET-21a*-NColE7-SRHS and pET-21a*-KGNK-SRHS plasmids resulting
the pET-21a*-NColE7-SRQS and pET-21a*-KGNK-SRQS plasmids in-
cluding a histidine (H) to glutamine (Q) mutation. We also inserted a
new oligonucleotide sequence between the SRQS and 6 × His tag codes
of the pET-21a*-NColE7-SRQS and pET-21a*-KGNK-SRQS plasmids to
obtain new plasmids, which were expected to express proteins with a
non-coordinating C-terminal extension instead of the 6 × His sequence.
The construction of the above plasmids and the sequences of expected
proteins are described in detail in the Supplementary material. The li-
gated plasmids, multiplied by competent E. coli cells were purified from
the bacteria by EZ-spin column plasmid DNA kit (Bio Basic Inc., Ca-
nada). The nucleotide sequences of the plasmids were verified by the
standard sequencing procedure.
2.3. Protein expression and purification
The KGNK-6 × His protein was expressed by the same method
described in our previous article [1] with changes during the pur-
ification procedure since the protein was eluted here from the Ni(II)-
nitrilotriacetic acid (NTA) resin without cleaving the 6 × His affinity
tag. The protein was expressed in BL21 (DE3) E. coli cells from the pET-
21a*-KGNK-SRHS expression plasmid by growing the bacteria first in
5 mL LB(amp+) media for ~6 h at 37 °C until the optical density
reached 0.6–1.0. This preculture was transferred into 250 mL LB(amp
+) medium (containing 0.1 mg/mL ampicillin) and incubated further
for ~4 h at 37 °C. The protein expression was induced by 150 μL iso-
propyl β-D-1-thiogalactopyranoside (IPTG; 200 mg/mL stock diluted to
~0.5 mM final concentration) when the optical density at 600 nm
(OD600) reached 0.9–1.0. After incubation for 3 h at 37 °C the cells were
collected by centrifugation at 4 °C, 4000 ×g for 15 min. The cells were
resuspended in 10 mL 1 × binding buffer containing 500 mM NaCl,
20 mM tris(hydroxymethyl)aminomethane hydrochloride (Tris-HCl;
pH 7.9), and 5 mM imidazole. The cells were lysed by ultrasonication
with a 50% amplitude setting for 6 × 30 s using a VCX 130 PB (130 W)
ultrasonic processor equipped with a 129 mm long and 13 mm diameter
titanium probe and the extract was centrifuged at 4000 ×g for 35 min
at 4 °C. After these preparatory steps, the KGNK-6 × His protein was
purified in batch type nickel-affinity chromatography. The sample was
filtered and loaded onto a Novagen His•Bind® resin preequilibrated
with 1 × binding buffer and rotated for 1 h at 4 °C. The bound protein
was washed 5 times with 2 × bed volume wash buffer (20 mM Tris-HCl
pH 7.9, 500 mM NaCl) containing increasing amounts of imidazole
(0–100 mM). After the washing steps, the protein was eluted from the
resin by using 0.25 × bed volume 1 × elution buffer (20 mM Tris-HCl,
pH 7.9, 500 mM NaCl, 1 M imidazole). The protein solution was buffer-
exchanged using Amicon Ultra 0.5 mL centrifugal filters with 3 kDa
molecular weight cut-off and stored in 20 mM 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid (HEPES, pH 7.7). Protein samples ob-
tained during the purification were analysed by tricine modified so-
dium dodecyl sulfate -polyacrylamide gel electrophoresis (SDS-PAGE)
using polyacrylamide gels prepared according to the protocol described
in ref. [41]. The bands were visualized by Coomassie Brilliant Blue
staining. Precision Plus Protein™ All Blue prestained protein standard
(BioRad) was run as a marker for comparison in each electrophoresis
experiment. The KGNK and NColE7 proteins were prepared as pre-
viously described [42].
2.4. Circular dichroism (CD) spectroscopy
Circular dichroism spectra were recorded on a Jasco J-815
Scheme 1. The amino acid sequence of the NColE7-6 × His protein. The arginine (R447) amino acid highlighted by the grey character background close to the N-
terminus was mutated to glycine (R447G mutation) to yield the KGNK-6 × His protein. H544, H569 and H573 metal ion-binding histidines are underlined in the
HNH motif (red characters), and the general base H545 histidine is underlined and also highlighted by the grey character background. The fusion sequence is in italic,
in which the SRHS nickel(II)-sensitive motif and the hexahistidine function is underlined. The numbering of the amino acids is based on the original Colicin E7 amino
acid sequence.
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spectropolarimeter while synchrotron radiation circular dichroism
(SRCD) spectra were acquired at the CD1 beamline of the storage ring
ASTRID at the ISA Centre for Storage Ring Facilities Aarhus, Aarhus
University, Denmark [43,44]. Camphor-sulfonic acid served as a cali-
bration material for the instrument. All spectra were recorded using
1 nm steps and a dwell time of 2 s, using quartz cells (SUPRASIL,
Hellma GmbH, Germany) with a 0.1 mm optical length, in the wave-
length range of 180–300 nm. Prior to the measurements, the protein
solutions were dialyzed against a 10 mM HEPES, pH 8.2 buffer. Spectra
were baseline-corrected by using the spectrum of water or buffer.
2.5. Inductively coupled plasma mass spectrometry experiments
An Agilent 7700× inductively coupled plasma mass spectrometer
(ICP-MS) was used for the quantitative measurement of total zinc
concentrations. The sample introduction system consisted of an Agilent
I-AS autosampler and a Micro Mist pneumatic nebulizer equipped with
a Peltier-cooled Scott-type spray chamber. The sample uptake rate was
400 μL/min. The ICP plasma and interface parameters were set up as
follows. Radio frequency forward power: 1550 W, plasma gas flow rate:
15.0 L/min, carrier gas flow rate: 1.05 L/min, sampling depth:
10.0 mm. In order to avoid possible spectral interferences, the mea-
surements were performed in He mode of the collision cell.
Measurements were carried out by monitoring the signal of the 66Zn
isotope. ICP-MS tuning was carried out by using standard solutions
supplied by Agilent (No. G1820-60410). Multipoint, matrix-matched
calibration was performed using a certified calibration standard
(Inorganic Ventures IV-ICPMS-71A). The 99.996% purity argon and
99.999% purity helium gas used was purchased from Messer
Hungarogáz (Hungary). ICP-MS data processing was performed within
the Agilent Mass Hunter (Santa Clara, California, USA) software.
Particular attention was paid to avoid zinc trace impurities during
analysis. All labware (polyethylene autosampler vials, certified poly-
methylpentene volumetric flasks, etc.) were thoroughly cleaned prior to
use with dilute ultra-trace quality nitric acid (VWR Chemicals,
Pennsylvania, USA), the same as the one used in the preparation of
calibration solutions and for the digestion of the proteins, and dried in
an ultra high efficiency particulate air filtered environment in a laminar
flow hood (Alpine K700). Trace-quality de-ionized labwater from a
Merck MilliPore Elix 10 equipped with a Synergy polishing unit
(Darmstadt, Germany) was used for preparing all solutions.
2.6. Mass spectrometric investigation of metal ion binding of the KGNK-
6 × His protein
Intact protein analysis was performed by mass spectrometry (MS)
on an Orbitrap EliteTM (Thermo Scientific) Hybrid Ion Trap-Orbitrap
Mass Spectrometer coupled with a TriVersa NanoMate (Advion) chip-
based electrospray ion (ESI) source. Prior to ESI-MS measurements, we
performed buffer exchange on the protein to 10 mM NH4HCO3 pH 8.0
buffer using Amicon Ultra 0.5 mL centrifugal filters with 3 kDa mole-
cular weight cut-off. The protein concentrations during the measure-
ments were 10 μM, as determined based on UV molar absorbances at
280 and 205 nm (Supplementary S1.2). All the masses were measured
in the Orbitrap mass analyzer in positive ion mode with 120 k resolu-
tion (R=120,000 at 400m/z). Protein intact masses (single protonated
forms) were determined by deconvolution using the Freestyle 1.6
software tool (Thermo Scientific).
2.7. Catalytic activity assays
BL21 (DE3) E. coli cells were transformed by different KGNK and
NColE7 plasmids with and without a 6-His affinity tag and incubated at
37 °C overnight in order to check the effect of His tag removal on the
bacterial growth.
pUC-EGFP (EGFP stands for the enhanced green fluorescence
protein, the gene of which is included in pUC-EGFP) plasmid was ap-
plied for DNA cleavage studies by NColE7, KGNK and KGNK-6 × His
proteins separately. The KGNK-6 × His protein concentration was kept
at 2.8 μM in the catalytic experiments. The DNA cleavage was per-
formed in the absence and presence of Zn2+ ions at various metal-to-
protein molar ratios from 0:1 to 10:1 to follow the effect of the metal
ion on the catalytic activity. The reaction mixtures were incubated at
37 °C for 2 h and the catalytic reaction was stopped by adding SDS to a
1% (m/V) final concentration. Then the DNA cleavage was checked by
loading the samples onto 1% (m/V) agarose gel, containing ethidium
bromide for visualization of the DNA. Electrophoresis was performed in
Tris/acetate/ethylenediaminetetraacetic acid (EDTA) buffer (40 mM
Tris, 20 mM acetic acid, and 1 mM EDTA, pH 8.0) using Bio-Rad Wide
Mini Sub CellVR GT applying 7 V/cm potential gradient. Gene Ruler
1 kb Plus DNA Ladder (Thermo Scientific) was also applied for com-
parison.
3. Results and discussion
3.1. DNA cloning and cytotoxicity experiments reflecting the catalytic
activity of the nucleases
Colicin E7 metallonuclease is used by E. coli to kill competing
bacteria under stress conditions. The N-terminal nuclease domain
(NColE7) enters the target cell and cleaves the chromosomal DNA non-
specifically, resulting in its cytotoxicity. The extremely high catalytic
activity of NColE7 is demonstrated by the fact that a single enzyme
molecule can kill the cell [45,46]. For this reason, the gene of the
NColE7 metallonuclease cannot be cloned into commercial DNA vectors
without the simultaneous cloning of the gene of its inhibitory protein
Im7 [40,47]. The minor leakage in the protein expression regulation of
the plasmids prevents bacterial survival, i.e. growth of colonies. Thus,
transformation of bacteria by DNA vectors and subsequent monitoring
of the colony growth on LB(amp+) agar plates provides information
about the nuclease mediated non-specific DNA cleavage within the cells
by the minute amounts of the protein expressed from the inserted gene.
Since the Zn2+ ion in the catalytic center is essential for the nuclease
activity, an important conclusion can also be drawn about the metal ion
binding ability of the enzyme or its mutants within the cells.
Recently, we have designed the new pET-21a*-SRHS carrier DNA
vector for protein purification by affinity chromatography on Ni(II)-
NTA resin. As a result of the protein expression from this vector, a C-
terminal hexahistidine peptide tag is fused to the target protein [1].
After inserting the genes of NColE7 and KGNK proteins into this vector
and transforming the bacterial cells with these newly created pET-21a*-
NColE7-SRHS and pET-21a*-KGNK-SRHS plasmids, bacterial colonies
appeared on the LB(amp+) agar plates. This suggests that the modified
6 × His tagged proteins show decreased catalytic activity compared to
NColE7 and KGNK, respectively. However, the absence of Im7 gene
during the cloning procedure enhances the selection of plasmids in-
cluding erroneous genes, which results in expressing non-toxic proteins.
Therefore, we have checked the nucleotide sequences of the cloned
genes. We could obtain the pET-21a*-NColE7-SRHS plasmid with the
error-free gene, expressing the expected NColE7-6 × His protein,
supporting the decreased catalytic activity. Nevertheless, the sequen-
cing experiments also revealed several pET-21a*-NColE7-SRHS plasmid
preparations containing wrong, randomly mutated NColE7 genes, from
which modified proteins with decreased or no toxicity could be ex-
pressed. The NColE7 nuclease sequence suffered from either random
point mutation or random mutation causing a reading frame shift
(Table 1). It is worth mentioning that some of the mutations occurred at
the same locations detected in our previous article [48], such as the
point mutation at D557 or frame shift at …IDIHRGK… amino acid se-
quence, the latter mutation affecting the H573 residue, essential for the
metal ion binding. At the same time the sequences of the verified pET-
21a*-KGNK-SRHS plasmids were in agreement with the expected
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sequence. Thus the cytotoxicity of the KGNK-6 × His protein seems to
be negligible compared to that of NColE7-6 × His.
After the identification of the pET-21a*-NColE7-SRHS and pET-
21a*-KGNK-SRHS plasmids containing the expected sequences, we have
applied these DNA constructs for the transformation of various bacterial
cells in order to study the influence of the affinity tag on the catalytic
activity of the target metallonucleases. These experiments are described
in detail in the chapter S1.3 and Fig. S1 in the Supplementary material.
The results reflect that the inhibition effect of the 6 × His tag is more
pronounced on the less active KGNK nuclease than on NColE7 in
agreement with the discussion above.
The Zn2+ ion in the active center of NColE7 has an essential role in
the catalytic mechanism. The scissile phosphodiester group of the
substrate can bind to the metal ion at the fourth coordination site, re-
placing the coordinated water molecule. Any additional histidine
within the C-terminal tag can influence this event. To monitor the
possible role of these histidines we have carried out mutation experi-
ments. First, we changed the code of histidine within the SRHS se-
quence to the code of glutamine (Q) resulting in pET-21a*-NColE7-
SRQS and pET-21a*-KGNK-SRQS plasmids. The sequencing results re-
vealed that the mutation of histidine of SRHS was successful in both
plasmids, but we could also detect random mutations in some of the
pET-21a*-NColE7-SRQS plasmids. Thus, the cytotoxicity of these plas-
mids in Mach1 and DH5α bacterial cells did not show significant
change as compared to the pET-21a*-NColE7-SRHS and pET-21a*-
KGNK-SRHS plasmids (data not shown).
The hexahistidine tag is expected to inhibit the catalytic reaction
when it binds to the catalytic Zn2+ ion. We modified the NColE7-SRQS
and KGNK-SRQS proteins by either inserting a stop codon before the
6 × His tag or changing the His tag sequence by a frame shift mutation,
but keeping the length of the protein (see detailed description in the
chapter S1.3, Scheme S1 and Fig. S2). Both modifications prevent the
expression of the inhibitory 6 × His sequence. Therefore, we expected
an increased catalytic activity and cytotoxicity of the new plasmids.
Fig. 1 shows the comparison of the effect of pET-21a*-Nucl-SRHS, pET-
21a*-Nucl-SRQS and pET-21a*-Nucl-SRQS-NoHistag plasmids (where
Nucl is either NColE7 or KGNK) on the bacterial colony formation with
BL21 cells optimized for protein expression. All the NColE7 containing
plasmids killed the cells, but for all KGNK plasmids colony formation
was observed. The latter result suggests that the C-terminal tag (even
without bearing strongly coordinating amino acid residues) can de-
crease the catalytic activity of KGNK through a non-specific steric ef-
fect, likely involving non covalent interactions with the active site, too.
Multiple explanations can account for these observations: (i) The
cooperative action of the N- and C-termini is required for NColE7 to
hydrolyze DNA. This kind of intramolecular allosteric activation me-
chanism may be sterically hindered by the C-terminal protein tag. This
phenomenon would allow the fine tuning of the enzyme by optimizing
the length of the affinity tag. The tagged enzyme can also be activated
by the tag removal from the protein via an optimally positioned hy-
drolytically sensitive amino acid sequence either by using a specific
protease or by Ni(II)-induced cleavage. (ii) The metal ion containing
active center at the C-terminus of NColE7 is close enough to the hex-
ahistidine sequence to allow the coordination of this motif to the free
site of the catalytic Zn2+ ion. This event would also inhibit the nuclease
action, as it prevents the metal ion coordination to the scissile phos-
phodiester group, which is an essential step of the DNA cleavage. In
such a mechanism of inhibition the enzyme could be reactivated by the
addition of metal ions, which can effectively compete with Zn(II) for the
hexahistidine binding site, but do not replace Zn(II) in the active center.
(iii) Furthermore, the hexahistidine tag may also form a ternary com-
plex with Zn2+ ions including the H545 residue, which is responsible
for the formation of the nucleophilic attacking hydroxide in the cata-
lytic reaction.
The inhibition most probably occurs through a complex mechanism,
involving the combination of the above eventualities. A further relevant
observation is that the inhibitory effect decreases the toxicity to an
extent, which is enough for protein expressing bacteria harboring the
KGNK-type plasmids to survive, but not for those transformed by the
more active NColE7-type plasmids.
3.2. Characterization of the purified protein by CD and ICP MS
measurements
Based on the above considerations we purified the KGNK-6 × His
protein as described in the Experimental section for further in vitro
catalytic experiments to learn more about the effect of His-tag on the
enzyme function. The results of the purification procedure are detailed
in chapter S1.4 of the Supplementary material. It is worth mentioning
that the yield of the pure KGNK-6 × His protein was ~0.3 mg from 1 L
culture, i.e. from ~4.0 g of wet cells which is at least 10 times less than
the yield we could achieve with e.g. the catalytically inactive ΔN4-
NColE7-6 × His protein previously [1]. This reflects that the 6 × His
attachment couldn't completely inhibit the nuclease activity of the
KGNK protein and the expressed protein is slightly toxic to the cells.
CD spectroscopy was applied to monitor the protein folding after
purification and to estimate the fractions of secondary structure ele-
ments. Evaluation of the CD spectrum of the KGNK-6 × His protein by
the BeStSel software [49] revealed that the relative α-helical content is
~14% (Fig. 2). As expected, this is slightly less than the α-helical
content of the Zn2+-loaded KGNK protein calculated by BeStSel: ~16%
[42,50]. The reason for this is that KGNK-6 × His is longer by 16 amino
acids due to its C-terminal fusion tag, displaying most probably non-
helical structure. This result suggests that the protein is in its func-
tionally folded form.
ICP-MS measurements with the same batch of the purified KGNK-
6 × His revealed that the protein was obtained in its Zn2+-loaded form
containing approximately one equivalent of metal ion (Table S1). Since
Zn2+ ions in the nuclease domains of Colicin E7 and Colicin E9 proteins
are bound extremely tightly in the HNH catalytic center, characterized
by an apparent dissociation constant Kd ~10−9 value [51,52], we
propose that the initially bound metal ion should be in the primary
metal ion-binding site in KGNK-6 × His, as well. The KGNK and NColE7
proteins were purified without metal ion, since the removal of the Im7
immunity protein under acidic conditions resulted in the loss of the
Zn2+ ions, too [42].
3.3. DNA cleavage experiments with the KGNK-6 × His protein
The cleavage of a randomly selected pUC-EGFP plasmid by the
KGNK-6 × His enzyme was monitored by agarose gel electrophoresis in
the presence of various amounts of Zn2+ ions. Upon single-strand
cleavage the most compact supercoiled (sc.) form of the plasmid was
turned into open circular (oc.) form, while double-strand cleavage
(occurring due to the accumulation of single strand DNA cleavage
products) resulted in the linear (lin.) form of the plasmid. Further
double strand cleavages fractionate the linear DNA into small fragments
of various size resulting in a smear on the agarose gel. As it is shown in
Fig. 3, the purified KGNK-6 × His protein has a moderate nuclease
activity. The band of the supercoiled form of the plasmid starts to de-
crease in intensity, while the band related to the linear form also
Table 1
Mutations found in the gene of NColE7 in the DNA cloning experiments.
Types of mutations Mutation site
Single point mutation S504L
D557G
Reading frame shift …IDIHRGK → …MIFTEVN…
…PGKA… → …ATLStop
…RKKFWE… → …VRNSGK…
…FDDFR… → …LMILStop
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appears. By adding Zn2+ ions to the reaction mixture in increasing
amounts we could observe an increase in the catalytic activity from a
~1:2 protein-to-Zn2+ molar ratio. The maximum of the DNA cleavage
activity was achieved between ~1:3 and 1:5 protein-to-Zn2+ molar
ratio. Under these conditions, the band of the supercoiled form com-
pletely disappears at 60 min; even the band related to the open circular
form shows a decreased intensity and smearing of the band of the linear
form occurs as a result of the fragmentation due to efficient catalytic
process. After a further increase of the metal ion concentration, at 1:10
protein-to-Zn2+ molar ratio, the catalytic activity started to decline
again.
These results are in agreement with the observation that the cata-
lytic activity of the KGNK-6 × His protein is decreased compared to the
KGNK protein (see Fig. S3 for comparison), due to the inhibition effect
of the C-terminal tag. However, the increase of the DNA cleavage ability
of the enzyme upon increasing metal ion-to-protein ratio suggests that
the added metal ion can compete for the 6 × His sequence, which
originally may bind to the free site of the catalytic Zn2+ ion (Scheme 2)
accounting for the coordinative inhibition. Thus, by binding to the
6 × His sequence, the added metal ion enhances the catalytic activity.
By saturating the histidines outside the catalytic center with one or two
Zn2+ ions H545 may also be metallated on further addition of metal
ion, preventing the generation of the OH− nucleophile by the side-
chain of this histidine residue. The higher is the metal ion excess the
higher is the probability of this type of coordination. This would cause
the decrease of the catalytic activity under such conditions. It cannot be
excluded that the second or third metal ion, which most probably bind
to the hexahistidine sequence, may also coordinate to H545, but the
extensive formation of such complex would result in inhibition of the
enzyme instead of the activation as observed in the catalytic experi-
ments.
3.4. Mass spectrometric analysis of the metal ion binding properties of the
KGNK-6 × His
ESI-MS experiments were carried out to verify the feasibility of the
hypothesis described in Scheme 2a concerning the formation of mono
and oligonuclear complexes of KGNK-6 × His. The experiments were
Fig. 1. Inhibition effect of pET-21a*-Nucl-SRHS, pET-21a*-Nucl-SRQS and pET-21a*-Nucl-SRQS-NoHistag plasmids (where Nucl is NColE7 – left – or KGNK – right)
on BL21(DE3) bacterial colony formation with and without His affinity tag. There is no colony formation when Nucl = NColE7, but a few bacterial colonies appeared
when Nucl = KGNK.
Fig. 2. Fitting of the far UV CD spectra of the KGNK-6 × His protein between 190 and 250 nm for determining the secondary structure fractions by the BeStSel
program. The result of the secondary structure estimation is shown in the inset.
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executed by gradually increasing the concentration of the metal ion up
to ~4 equivalents of Zn2+ relative to the protein. The results of the
measurements are presented in Fig. 4. As the ICP-MS measurements
indicated, the KGNK-6 × His protein binds approximately one
equivalent of Zn2+. The mass spectrum without adding additional
metal ion (Fig. 4a), shows the presence of the ZnP monocomplex
(where P denotes the protein) as the major species, while the Zn2P
complex containing two metal ions also appears.
The mass spectrometric experiments (Fig. 4a–d) revealed that the
KGNK-6 × His protein is able to bind more metal ions. Up to 6 bound
Zn2+ ions have been detected by ESI-MS. Based on these measurements
the relative amounts of the complexes containing various number of
Fig. 3. Top: Agarose gel electrophoresis images showing the cleavage of pUC-EGFP (74 μM for nucleotide pairs) by 2.8 μM KGNK-6 × His protein containing
increasing amounts of Zn2+ ions. Each column in one experiment represents the catalytic activity after 0, 15, 60, 120 min, from left to right. Gene Ruler 1 kb Plus
DNA Ladder (Thermo Scientific) was loaded as a reference, and the untreated pUC-EGFP plasmid for negative control. Bottom: Evaluation of the gel pictures by
ImageJ program [53,54] for quantitation of the various forms of DNA.
Scheme 2. (a) Coordination of histidine residues inside the KGNK-6 × His to an increasing number of Zn2+ ions in parallel with the increase of the Zn2+: protein
molar ratio. (b) Interaction of Zn2+ ion, bound to histidines inside the KGNK active center, with an external chelator, such as the KQ peptide (see below) modelling
the Zn2+-interaction of the His tag of KGNK-6 × His. The histidines, coordinating to Zn2+ ion inside the nuclease active center, are green. H545 is orange, while
other histidines outside the native NColE7 sequence are marked red. (In grey scale the histidines coordinating to Zn2+ ion inside the nuclease active center are
medium, the H545 is light, while other histidines outside the native NColE7 sequence are dark grey.)
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metal ions were estimated and plotted versus the added Zn2+ equiva-
lents (Fig. 4e). For this, we identified the major peaks of the mass
spectra in Fig. 4a–d and assigned them to the potential Zn2+–KGNK-
6 × His species which could be present in the solution (from the
monocomplex till the six Zn2+ containing adduct). The observed Na+
and K+ adducts were also taken into account during the calculations.
Fig. 4. Deconvoluted monoisotopic MH+ m/z spectra of the KGNK-6 × His protein solution containing increasing amounts of Zn2+. (a) The protein solution with
approximately 1 equivalent of Zn2+. (b), (c) and (d) after the addition of further 0.5, 1.0 and 3.0 equivalents of Zn2+, respectively. Panel (e) shows the estimated
relative abundance of the various metal complexes of the protein as a function of the added Zn2+ equivalents. Green colour refers to the ZnP (Zn2+: protein = 1: 1)
monocomplex; Zn2P is marked with blue, Zn3P with red; while the orangish colours refer to the further Zn2+ adducts containing more metal ions. (In grey scale the
ZnP is medium and Zn2P is dark grey. Zn3P is black, while the further Zn2+ adducts are light greys.)
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The list of the peaks considered for the calculation of the relative
abundance diagram is shown in Supplementary Table S2. We summed
up the intensities of the peaks belonging to the same species at each
titration state and then plotted the percentage of these complexes in
Fig. 4e. The maximal percentage of the Zn2P complex of KGNK-6 × His,
expected to be catalytically most active, is observed in the presence of
~1.0–2.0 equivalents of Zn2+. Compared to the catalytic activity of the
KGNK-6 × His as a function of the Zn2+ concentration, this would infer
that the Zn3P species could still be active, while the increasing metal
ion concentration results in further coordinated Zn2+ ions and inhibi-
tion of the nuclease action. Although some of the detected complexes
may not form in significant amounts in dilute aqueous solutions and
under the conditions applied in the catalytic experiments, these results
support the assumption presented in Scheme 2a and the clearer inter-
pretation of the catalytic properties of the enzyme, too.
3.5. Modelling the inhibition mechanism of 6 × His in KGNK-6 × His
In order to further examine the type of inhibition by the C-terminal
6 × His tag we investigated the catalytic activity of the NColE7 and
KGNK proteins as purified earlier [42], in the presence of metal ion
chelators mimicking the coordinative interactions with the Zn2+ ion
within the active center. The Ac-Lys-His-Pro-His-Pro-His-Gln-NH2
heptapeptide (further denoted as KQ) containing three histidine re-
sidues [55] could not effectively inhibit the activity of the NColE7.
NColE7 possesses a very high catalytic activity: it starts to cleave DNA
instantly after mixing them together and completely fragmentates the
plasmid DNA after 15 min. Under such conditions, the inhibitory effect
of the KQ peptide was not observable. However, with KGNK (which has
at least 10 times lower activity [42,56]) we could observe the decrease
of the DNA cleavage ability as an effect of the presence of the chelator
(Fig. S3). The KGNK enzyme causes heavy fragmentation after one hour
incubation, while in the presence of 10 equivalents of KQ peptide the
linear form is still visible, demonstrating partial inhibition of the cat-
alytic process. This result is consistent with the above experiments in E.
coli cells showing the extreme activity of NColE7 which could not be
completely inhibited even with the hexahistidine sequence attached to
the C-terminus, and therefore, it was not possible to express the
NColE7-6 × His protein and the other NColE7 containing constructs.
We also carried out similar inhibition experiments with a bis-imi-
dazolyl peptide Gly-BIMA (inset of Fig. 5) able to chelate metal ions
through the two imidazole ring nitrogens [57–59]. Applying a de-
creased nuclease concentration as compared to the experiments with
the KQ peptide, the inhibition effect of the peptide was clearly visible
even with the NColE7 protein. Mostly the linear form of the DNA was
detected after 60 min in the presence of chelator excess, while the
NColE7 itself caused heavy DNA fragmentation. The catalytic activity of
KGNK was so efficiently inhibited that even the supercoiled form of
DNA was still detectable after 60 min in the presence of the competitor
(Fig. 5).
One may expect two possible inhibition pathways: the imidazole
rings coordinate to the free site of the catalytic Zn2+ ion or they remove
the Zn2+ ion from the active center. Although the Zn2+ ion binding
affinity of the KQ [55] or Gly-BIMA [57–59] chelators is much smaller
than that of the HNH catalytic center, we could not exclude the possi-
bility that the decrease of the catalytic activity is related to competition
for the Zn2+ ions i.e., the decrease of the concentration of the active
catalyst. To better understand the inhibition mechanism, we carried out
CD measurements in the presence of the achiral Gly-BIMA. Previously
we reported that there is a slight but significant difference in the CD
spectra of the apo and holo forms of NColE7 and its mutants [42]. In
two separate experiments we added Gly-BIMA and EDTA to the Zn2+-
loaded KGNK protein and measured the CD spectra of both solutions
(Fig. 6). No change of the protein spectrum was detectable even in the
presence of 50 equivalents of the achiral peptide, while EDTA yielded a
spectrum identical to that of the apoenzyme. This suggests that the
imidazole rings can only bind to the free coordination site of the Zn2+
ion inside the catalytic center forming ternary complexes, while the
metal ion remains bound to the protein such as it is depicted in Scheme
2b. This is a remarkable achievement in elucidating the coordinative
inhibitory effect of the 6 × His affinity tag on the metallonuclease
activity. A similar modelling of the metal ion affinity tag by an external
heptahistidine containing oligopeptide sequence was not successful
[13]. The lack of any interference with the enzyme activity suggested
only non-specific steric effects of the tag on the TNF proteins [13].
3.6. Influence of the His tag on the structural integrity of KGNK-6 × His
Temperature dependent SRCD measurement series were carried out
with NColE7 and KGNK-6 × His proteins in the presence and absence of
metal ion with the aim to study the thermal stability of the enzyme.
Earlier it was suggested that the removal of the metal ion decreases
thermal stability [60]. The results shown in Fig. 7 indicate that the
changes in the structure of the enzyme do not occur in a single step.
The first conformational change occurred between 25 and 35 °C and
this was significantly affected by the removal of the metal ion from the
enzyme. Then the main melting process took place around 49 °C. This
probably reflects the conformational change of the central helical
Fig. 5. Digestion of 28 nM pUC-EGFP (75 μM calculated for base pairs) by 0.28 μM NColE7 and 1 μM KGNK in 20 mM HEPES buffer (pH 7.7) in the absence or
presence of increasing amounts of Gly-BIMA chelating agent. The samples were kept at 37 °C. The reactions were stopped by 1% (m/V) SDS, freezing and subse-
quently run on 1% (m/V) agarose gel. Gene Ruler 1 kb Plus DNA Ladder (Thermo Scientific) served as the reference. The inset shows the chemical formula of the Gly-
BIMA bis-imidazolyl peptide.
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regions of the protein, which is not significantly influenced by the metal
ion. For NColE7 the changes occurring between 30 and 40 °C were less
pronounced, and the metal ion had only a slight effect (Fig. S4). The
curves recorded in the presence of metal ion could be satisfactorily
fitted with a single process with a melting point around 50 °C. The main
melting process occurred at the same temperature for NColE7 when the
metal ion was removed from the catalytic center.
The melting process at low temperature is most probably related to
the HNH motif, which might be slightly more flexible and thus, more
sensitive to the increasing temperature in the absence of the metal ion.
This sensitivity seemed to be more prononounced for the KGNK-6 × His
protein. A plausible explanation may be that the C-terminal fusion tag
destabilized the interaction between the two termini of NColE7, which
is responsible for the stabilization of the structure of the preformed
catalytic site [61]. This effect is, however, influenced by the metal ion,
suggesting that the coordinated His tag has a negligible disturbing ef-
fect on the structure of the HNH motif. This also supports the above
observations, that the complex effect of the 6 × His sequence involves
steric hindrance, but it also inhibits the enzyme activity by binding to
the metal ion in the catalytic center.
4. Conclusions
The 6 × His tag, allowing metal ion affinity chromatographic
purification, can also influence the properties of proteins. We showed
that even the extremely active NColE7 metallonuclease could be par-
tially inhibited by coordinative (involving the Zn2+ containing active
center) and non-specific steric interactions of 6 × His sequence.
Monitoring the cytotoxicity, originating from the non-specific de-
gradation of the bacterial DNA, showed that the Mach1 and DH5α cells
with minute protein expression leakage could survive, but BL21(DE3)
cells with less regulated protein expression died when transformed with
plasmids containing the NColE7 gene. At the same time the cytotoxic
effect of the R447G (KGNK) mutant protein could be reduced to a level
allowing the expression and purification of the KGNK-6 × His protein.
In vitro catalytic activity experiments with KGNK-6 × His revealed
that the addition of Zn2+ excess to the holoprotein results in a complex
behavior. The rate of DNA cleavage increased up to a metal-to-protein
molar ratio of 3–5: 1, while further excess of metal ion caused inhibi-
tion of the catalytic process. The first phenomenon can most probably
be explained by the competition of the Zn2+ excess for the 6 × His
sequence, thereby deliberating this motif from the catalytic Zn2+ site.
This would result in the activation of the enzyme. In high excess,
however, Zn2+ may also coordinate to the H545 residue, which has an
essential role in the DNA hydrolysis via generating the nuclephylic
OH−. We attempted to simulate these complex formation processes by
estimating and refining the apparent stabilities of the ZnxP species to
Fig. 6. CD spectra of the KGNK protein in the presence and absence of metal ion and/or various chelators. All spectra were normalized to the same 31.6 μM protein
concentration.
Fig. 7. Temperature dependent SRCD spectra of the Zn2+-loaded (top) and apo
(bottom) forms of the KGNK-6 × His protein.
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obtain the species distribution best describing the catalytic and MS
experiments. Up to four bound metal ions were included considering
the number of binding sites potentially offering stability, which is high
enough to enable the complex formation in micromolar concentration
range. The logK′ values obtained in this way are ~9.0 for ZnP; ~5.3 for
~Zn2P; ~4.9 for Zn3P and ~4.7 for Zn4P. The first value is in agree-
ment with those published for the Zn2+ affinity towards the HNH active
center [51,52]. The values for Zn2P and Zn3P are consistent with Zn2+
coordination towards the oligohistidine peptides binding one or two
metal ions [29,55,62]. The hypothetical distribution diagram (Fig. 8)
shows that the formation of Zn4P species becomes significant at> 5
fold Zn2+ excess. Since under such conditions the inhibition of the DNA
hydrolysis can be observed in accordance with the literature data on
NColE7 itself [63], we suppose that the coordination site in Zn4P is
most probably the H545 residue. Taking this into account, the stability
related to the binding of the fourth metal ion is fairly high. An ex-
planation of this could be a stability enhancing effect of further amino
acid side-chains available for metal ion binding together with H545.
These considerations, well supported by the ESI-MS results (see the
distribution diagram for the MS conditions in Supplementary Fig. S5),
may help to better understand the catalytic behavior of the KGNK-
6 × His protein in the presence of increasing amounts of Zn2+. Based
on this model, the catalytically active species are the Zn2P and Zn3P
complexes with one or two Zn2+ ions bound to the oligohistidine
moiety while the metal ion in the active center can catalyze the DNA
hydrolysis.
The applied KQ or Gly-BIMA chelators could experimentally model
the coordinative inhibitory effect of the 6 × His fusion sequence on the
catalytic activity of the investigated metallonucleases, although this
effect is less pronounced than that of the covalently attached 6 × His
tag. We showed that the affinity tag exerts a non-specific steric in-
hibitory effect, too. Based on these findings, the catalytic activity of the
NColE7 or other similar metalloenzymes can be modulated in multiple
manner without changing the core enzyme sequence. By the increase of
the concentration of competing metal ions the saturation of the 6 × His
tag can be achieved and this may decrease its coordinative inhibition
effect. A more drastic action to activate the enzyme could be the re-
moval of the whole inhibitory tag by a specific protease mediated hy-
drolysis, e.g. by a Ni2+ ion-induced peptide bond cleavage. The rede-
sign of the metal binding properties of the C-terminal tag also offers
multiple opportunities for the fine tuning of the catalytic activity.
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